About Genomics plc
Genomics plc news and updates
Genomics received financing of $13.9M in Series B financing round on Sep 1st 18'.
Additionally, Vertex has made a £10.5 million equity investment in Genomics plc as part of its £25 million Series B funding round also announced today.
Jan 1, 2018 | globalpharmaupdate.comGenomics hires Chas Bountra as Professor
Genomics plc is pleased to announce the appointment of Professor Chas Bountra to Genomics plc’s Scientific Advisory Board.
Jan 1, 2016 | genomicsplc.comGenomics partnered with Institute of Public Health & Hygiene on Sep 28th 21'.
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a diversified Genomics and AI driven preventative health business today announced that they have entered into a strategic collaboration with the Institute of Public Health in St Louis USA for the purpose of expanding the predictive capabilities of the GeneType for Breast Cancer product to include women of African descent.
Jan 1, 2021 | stockhouse.comGenomics hires Mitchell Harris as Global Head, Emerging Business Lines
Genomics plc strengthens leadership team with the addition of Mitchell Harris as Chief Strategy Officer and Professor Gil McVean as Chief Information Officer.
Jan 1, 2020 | genomicsplc.comGenomics hired Jeff Barrett as Chief Scientific Officer and Director on Jan 16th 18'.
Oxford, UK, 16 January 2018: Genomics plc is delighted to announce that Dr Jeff Barrett will be joining Genomics plc as Chief Scientific Officer and Director.
Jan 1, 2018 | genomicsplc.comGenomics hires Daniel as CFO
Daniel brings to Genomics plc substantial expertise in areas ranging from strategy and corporate planning, financing, and data science.
Jan 1, 2020 | genomicsplc.comGenomics received financing of $30M in funding round on Mar 1st 21'.
Meanwhile, earlier this month, Genomics plc announced a $30 million oversubscribed funding round.
Jan 1, 2021 | mobihealthnews.comVertex Pharmaceuticals, Inc. invests into Genomics in $13.6M
In addition to the collaboration, Vertex also invested $13.6 million into a Series B financing round for Genomics plc.
Jan 1, 2018 | biospace.comNHS partners with Genomics
This could change, as the NHS announced a pilot project with Genomics PLC to identify those who present high risks of cardiovascular disease (CVD) from genetic data.
Jan 1, 2021 | luxresearchinc.comGenomics is developing precision healthcare tools
Genomics plc uses large-scale genetic information to develop precision healthcare tools, working within the new area of genomic prevention.
Jan 1, 2021 | pharmatimes.comGenomics is developing precision cancer therapies on Apr 8th 22'.
Apr. 8, 2022 Lantern Pharma (NASDAQ: LTRN) is a clinical stage oncology-focused company who is harnessing the power of Artificial Intelligence and Genomics to develop precision cancer therapies.
Jan 1, 2022 | redchip.comGenomics hired Mark Toms as Chief Medical Officer and Chief Commercial Officer on Nov 25th 22'.
Genomics plc has today announced that Mark Toms and Nick DeFilippo have joined its leadership team as Chief Medical Officer and Chief Commercial Officer, respectively.
Nov 24, 2022 | genomicsplc.comGenomics hired Nick DeFilippo as Chief Medical Officer and Chief Commercial Officer on Nov 25th 22'.
Genomics plc has today announced that Mark Toms and Nick DeFilippo have joined its leadership team as Chief Medical Officer and Chief Commercial Officer, respectively.
Nov 24, 2022 | genomicsplc.com